OFSEP
Showing 1 - 19 of 19
OFSEP Very High Definition Cohort
Not yet recruiting
- Multiple Sclerosis
- MRI
-
Lyon, France
- +4 more
Nov 14, 2022
Multiple Sclerosis in Elderly: Epidemiology, Clinical and MRI
Completed
- Multiple Sclerosis
-
Bordeaux, France
- +2 more
Feb 2, 2022
Multiple Sclerosis Trial in France, Martinique
Active, not recruiting
- Multiple Sclerosis
-
Amiens, France
- +26 more
Aug 24, 2021
Serum Neurofilament-light Chain and GFAP Levels in Patients From
Recruiting
- Multiple Sclerosis
- Blood sample
-
Amiens, France
- +27 more
Jul 30, 2021
Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related
Recruiting
- Sclerosis, Multiple
- +3 more
- No intervention
-
Amiens, France
- +33 more
Mar 21, 2022
Modifications of Environmental Exposures and Health Care Access
Recruiting
- Multiple Sclerosis
- questionnaire
-
Paris, FranceNeurology Department, Hopital de la Pitié Salpêtrière
Mar 4, 2022
Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic
Recruiting
- Multiple Sclerosis, Primary Progressive
- Multiple Sclerosis, Secondary Progressive
- Magnetic Resonance Imaging
- +3 more
-
Marseille, France
- +1 more
Jan 14, 2022
Multiple Sclerosis Trial in Nantes (Biological sample collection)
Recruiting
- Multiple Sclerosis
- Biological sample collection
-
Nantes, Loire-Atlantique, FranceNantes University Hospital
Jan 27, 2023
Lymphocyte Reconstitution After Lymphopenia in Participants
Completed
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Dimethyl fumarate
-
Amiens, France
- +31 more
Oct 18, 2021
Myocardial Infarction Trial in Bron, Lyon (other, biological, behavioral)
Not yet recruiting
- Myocardial Infarction
- MRI
- +2 more
-
Bron, Rhone, France
- +1 more
Mar 20, 2023
Multiple Sclerosis, Relapsing-Remitting Trial in France (drug, procedure, behavioral)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection
- +4 more
-
Besançon, France
- +3 more
Oct 18, 2021
Ella Platform for Serum Nfl And GFAP Measures In Multiple
Active, not recruiting
- Multiple Sclerosis
- Biomarker quantification
-
Clermont-Ferrand, France
- +9 more
Apr 25, 2022
Relapses in Biotin-treated Progressive Multiple Sclerosis
Unknown status
- Progressive Multiple Sclerosis
- biotin
- propensity score
-
Clermont-Ferrand, FranceCHU Clermont-FERRAND
May 29, 2018
COVID-19 in Patients With MS or NMO
Unknown status
- Multiple Sclerosis
- +2 more
- Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2)
-
Paris, FranceHôpital Pitié Salpétrière
Apr 28, 2020
Safety of Exposure to Natalizumab During Pregnancy
Recruiting
- Multiple Sclerosis
- Questionnaire
-
Besançon, France
- +26 more
Jun 27, 2022
Potential Accumulation of Gadolinium in French Observatory of
Unknown status
- Multiple Sclerosis
- Unenhanced MRI
- (no location specified)
Dec 12, 2016
Multiple Sclerosis Trial in Caen (My eReport France)
Completed
- Multiple Sclerosis
- My eReport France
-
Caen, FranceCHU Caen
Jul 1, 2019
Clinical Decision Support System (CADIMS) for MS Diagnostic
Unknown status
- Multiple Sclerosis, Relapsing-Remitting
-
Brest, France
- +5 more
Sep 10, 2018
The French Multiple Sclerosis Registry
Unknown status
- Multiple Sclerosis
- Neuromyelitis Optica Spectrum Disorders
-
Bron, FranceHospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer
Sep 6, 2016